Wednesday, October 04, 2006

More Info on Human Genome Science's HGS004

Turns out this drgu is a fully human monoclonal antibody to a specific receptor on cells. The receptor is called CCR5, which is one of the receptors the virus uses to enter cells. The antibody blocks this receptor, and probably causes it to be interalized, which prevents further cells being infected with the drug.

With less than an hour remaining in trading today, HGSI (NASDAQ) is up 42 cents to $12.43 in very heavy trading. I look for this stock to keep going up.

No comments: